A once abandoned drug compound shows an ability to rebuild organs damaged by illness and injury.
Read moreA Drug Shows an Astonishing Ability to Regenerate Damaged Hearts and Other Body Parts
Novo Biosciences achieves major milestones in moving trodusquemine into clinical trials
Novo Biosciences Inc., has achieved several major milestones in its mission of bringing its breakthrough drug candidate, trodusquemine (aka MSI-1436), to market as a potential regenerative medicine treatment for heart disease and Duchenne...
Read moreNovo Biosciences Receives Federal Grant to Advance Potential Heart Drug
Novo Biosciences Inc. has announced that it has received a two-year, $1.5 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for the development of MSI-1436 as a potential regenerative medicine...
Read moreLooking beyond stem cells and tissue engineering: What if lost and damaged tissues and organs could be regenerated simply by taking a drug?
While stem cell and tissue engineering approaches may ultimately deliver on their clinical promise, small molecules that control innate regeneration mechanisms offer a less complex and more economical path to realizing regenerative medicine’s...
Read moreDrug Could Regenerate Damaged Tissue After a Heart Attack, Study Suggests
US researchers claim to have identified a groundbreaking drug that could restore heart muscle function following a heart attack. A new study describes how MSI-1436, a naturally occurring compound, regenerates heart muscle tissue in zebrafish and...
Read moreNovo Biosciences Scientists Receive Patent to Develop Molecule that Could Repair Heart Tissue
A federal patent has been awarded to scientists at Novo Biosciences, a step that will allow research to proceed on a molecule that shows promise in helping heart tissue regenerate after a heart attack.
Read more